Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study

被引:12
|
作者
Muyoyeta, Monde [1 ]
Kerkhoff, Andrew D. [2 ,3 ]
Chilukutu, Lophina [1 ]
Moreau, Emmanuel [4 ]
Schumacher, Samuel G. [4 ]
Ruhwald, Morten [4 ]
机构
[1] Ctr Infect Dis Res Zambia, Lusaka, Zambia
[2] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Div HIV Infect Dis & Global Med, San Francisco, CA 94117 USA
[3] Univ Calif San Francisco, Ctr Trauma, Div HIV Infect Dis & Global Med, San Francisco, CA 94117 USA
[4] Fdn Innovat New Diagnost FIND, Geneva, Switzerland
关键词
MYCOBACTERIUM-TUBERCULOSIS; XPERT MTB/RIF;
D O I
10.1183/13993003.03999-2020
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background A novel, rapid, point-of-care urine-based lipoarabinomannan assay (Fujifilm SILVAMP TB LAM ("FujiLAM")) has previously demonstrated substantially higher sensitivity for tuberculosis (TB) compared with the commercially available Determine TB LAM assay using biobanked specimens. However, FujiLAM has not been prospectively evaluated using fresh urine specimens. Therefore, we determined the diagnostic accuracy of FujiLAM among HIV-positive and HIV-negative outpatients with presumptive TB in Zambia. Methods Adult (> 18 years old) presumptive TB patients presenting to two outpatient public health facilities in Lusaka were included. All patients submitted sputa samples for smear microscopy, Xpert MTB/RIF and mycobacterial culture, and urine samples for the FujiLAM assay. Microbiologically confirmed TB was defined by the detection of Mycobacterium tuberculosis in sputum using culture; this served as the reference standard to assess the diagnostic accuracy of FujiLAM. Results 151 adults with paired sputum microbiological tests and urine FujiLAM results were included; 45% were HIV-positive. Overall, 34 out of 151 (23%) patients had culture-confirmed pulmonary TB. The overall sensitivity and specificity of FujiLAM was 77% (95% CI 59-89%) and 92% (95% CI 86-96%), respectively. FujiLAM's sensitivity among HIV-positive patients was 75% (95% CI 43-95%) compared with 75% (95% CI 51-91%) among HIV-negative patients. The sensitivity of FujiLAM in patients with smear-positive, confirmed pulmonary TB was 87% (95% CI 60-98%) compared with 68% (95% CI 43-87%) among patients with smear-negative, confirmed pulmonary TB. Conclusions FujiLAM demonstrated high sensitivity for the detection of TB among both HIV-positive and HIV-negative adults, and also demonstrated good specificity despite the lack of systematic extrapulmonary sampling to inform a comprehensive microbiological reference standard.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Point-of-care ultrasound for tuberculosis diagnosis in children: a Médecins Sans Frontières cross-sectional study in Guinea-Bissau
    Moreto-Planas, Laura
    Sagrado, Maria Jose
    Mahajan, Raman
    Gallo, Jonathan
    Biague, Evelize
    Goncalves, Ramiro
    Nuozzi, Pablo
    Rocaspana, Merce
    Fonseca, Jamila Vieira
    Medina, Candida
    Camara, Miguel
    Nadimpalli, Adi
    Alonso, Beatriz
    Llosa, Augusto E.
    Heuvelings, Lotje
    Burza, Sakib
    Molina, Israel
    Ruby, Lisa C.
    Stratta, Erin
    Belard, Sabine
    BMJ OPEN, 2023, 13 (05):
  • [42] Use of point-of-care C-reactive protein testing for screening of tuberculosis in the community in high-burden settings: a prospective, cross-sectional study in Zambia and South Africa (vol 11, e704, 2023)
    Ruperez, M.
    Shanaube, K.
    Mureithi, L.
    Burnett, James M.
    LANCET GLOBAL HEALTH, 2023, 11 (07): : E1011 - E1011
  • [43] Analytical performance of eight rapid point-of-care tests routinely used for the detection of HBsAg in Burkina Faso: A cross-sectional study
    Sanou, Armel M.
    Toye, Rayana
    Kagone, Therese
    Nikiema, Abdoulaye
    Testa, Jean
    Sakande, Jean
    Sangare, Lassana
    Tarnagda, Zekiba
    Kania, Dramane
    JOURNAL OF CLINICAL VIROLOGY, 2020, 129
  • [44] Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy
    Dorward, Jienchi
    Lessells, Richard
    Govender, Katya
    Moodley, Pravi
    Samsunder, Natasha
    Sookrajh, Yukteshwar
    Turner, Phil
    Butler, Christopher C.
    Hayward, Gail
    Gandhi, Monica
    Drain, Paul K.
    Garrett, Nigel
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2023, 26 (09)
  • [45] Knowledge, attitude, and practices regarding childhood tuberculosis detection and management among health care providers in Cambodia: a cross-sectional study
    An, Yom
    Teo, Alvin Kuo Jing
    Huot, Chan Yuda
    Tieng, Sivanna
    Khun, Kim Eam
    Pheng, Sok Heng
    Leng, Chhenglay
    Deng, Serongkea
    Song, Ngak
    Nop, Sotheara
    Nonaka, Daisuke
    Yi, Siyan
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [46] Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study
    Penn-Nicholson, Adam
    Georghiou, Sophia B.
    Ciobanu, Nelly
    Kazi, Mubin
    Bhalla, Manpreet
    David, Anura
    Conradie, Francesca
    Ruhwald, Morten
    Crudu, Valeriu
    Rodrigues, Camilla
    Myneedu, Vithal Prasad
    Scott, Lesley
    Denkinger, Claudia M.
    Schumacher, Samuel G.
    LANCET INFECTIOUS DISEASES, 2022, 22 (02): : 242 - 249
  • [47] Enhanced tuberculosis screening using computer-aided X-ray diagnosis and novel point of care urine lipoarabinomannan assay among adults with HIV admitted to hospital (CASTLE study): a cluster randomised trial
    Burke, R.
    Nyirenda, S.
    Twabi, H.
    Nliwasa, M.
    Joekes, E.
    Walker, N.
    Nyirenda, R.
    Gupta-Wright, A.
    Fielding, K.
    MacPherson, P.
    Corbett, E.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 216 - 216
  • [48] Trial Design of a Prospective Multicenter Diagnostic Accuracy Study of a Point-of-Care Test for the Detection of Taenia solium Taeniosis and Neurocysticercosis in Hospital-Based Settings in Tanzania
    Trevisan, Chiara
    Damme, Inge
    Ngowi, Bernard
    Schmidt, Veronika
    Stelzle, Dominik
    Moller, Karen
    Kabululu, Mwemezi
    Makasi, Charles
    Magnussen, Pascal
    Bottieau, Emmanuel
    Abatih, Emmanuel
    Johansen, Maria
    Ngowi, Helena
    Ndawi, Benedict
    Mwape, Kabemba
    Zulu, Gideon
    Dorny, Pierre
    Winkler, Andrea
    Gabriel, Sarah
    DIAGNOSTICS, 2021, 11 (09)
  • [49] Protocol for a prospective, controlled, cross-sectional, diagnostic accuracy study to evaluate the specificity and sensitivity of ambulatory monitoring systems in the prompt detection of hypoxia and during movement
    Areia, Carlos
    Vollam, Sarah
    Piper, Philippa
    King, Elizabeth
    Ede, Jody
    Young, Louise
    Santos, Mauro
    Pimentel, Marco A. F.
    Roman, Cristian
    Harford, Mirae
    Shah, Akshay
    Gustafson, Owen
    Rowland, Matthew
    Tarassenko, Lionel
    Watkinson, Peter J.
    BMJ OPEN, 2020, 10 (01):
  • [50] Hepatitis C Virus Antibody Positivity and Predictors Among Previously Undiagnosed Adult Primary Care Outpatients: Cross-Sectional Analysis of a Multisite Retrospective Cohort Study
    Smith, Bryce D.
    Yartel, Anthony K.
    Krauskopf, Katherine
    Massoud, Omar I.
    Brown, Kimberly A.
    Fallon, Michael B.
    Rein, David B.
    CLINICAL INFECTIOUS DISEASES, 2015, 60 (08) : 1145 - 1152